Opioids in patients with renal impairment Renal impairment can reduce the elimination of certain opioids and their metabolites. Accumulation and toxicity may occur. Due to their pharmacokinetic properties, fentanyl, alfentanil and buprenorphine can be used safely in patients with renal impairment. Codeine and pethidine should be avoided entirely. Morphine should also be avoided if the creatinine clearance is below 30 ml / min. Reduced dose hydromorphone is an alternative here. Methadone, oxycodone and tramadol should be used with caution and in reduced doses. In this article we briefly explain the renal elimination processes, certain pharmacokinetic properties of the different opioids and the recommendations for clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a001144DOI Listing

Publication Analysis

Top Keywords

patients renal
12
renal impairment
12
pharmacokinetic properties
8
renal
5
[opioids patients
4
renal impairment]
4
impairment] opioids
4
opioids patients
4
impairment renal
4
impairment reduce
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!